DESY’s X-ray source PETRA III points possible ways to better RNA vaccines
The pharmaceutical company BioNTech and the University of Mainz are conducting research with other partners on the EMBL beamline
04-Dec-2020 -
The Mainz-based biotech company BioNTech, which recently presented the first promising results for a coronavirus vaccine together with the US company Pfizer, is already conducting research on the next generation of RNA drugs at DESY’s X-ray source PETRA III. Using the P12 beamline, operated by ...
BioNTech
coronaviruses
mRNA vaccines
+3